Ran Xu

1.4k total citations
48 papers, 932 citations indexed

About

Ran Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ran Xu has authored 48 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Ran Xu's work include Ferroptosis and cancer prognosis (11 papers), RNA modifications and cancer (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Ran Xu is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), RNA modifications and cancer (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Ran Xu collaborates with scholars based in China, United States and Italy. Ran Xu's co-authors include Seiichi P. T. Matsuda, Tong Lu, Jiaying Zhao, Linyou Zhang, Bo Peng, Huawei Li, Shengqiang Zhang, Qi Li, Jun Wang and Pengfei Zhang and has published in prestigious journals such as Journal of the American Chemical Society, The EMBO Journal and Nature Neuroscience.

In The Last Decade

Ran Xu

45 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Xu China 12 629 113 105 94 89 48 932
Tae Woo Kim South Korea 16 477 0.8× 107 0.9× 159 1.5× 60 0.6× 74 0.8× 34 820
Ming‐Cheng Chen Taiwan 16 480 0.8× 201 1.8× 144 1.4× 65 0.7× 67 0.8× 50 936
Ji‐Fan Lin Taiwan 19 541 0.9× 127 1.1× 241 2.3× 79 0.8× 51 0.6× 43 950
Young-Woo Jin South Korea 16 660 1.0× 192 1.7× 134 1.3× 82 0.9× 137 1.5× 41 1.1k
Debra L. Bemis United States 13 557 0.9× 189 1.7× 165 1.6× 180 1.9× 84 0.9× 21 1.0k
Sun‐Mi Yun South Korea 17 484 0.8× 117 1.0× 97 0.9× 98 1.0× 36 0.4× 35 855
Dan Huang China 18 432 0.7× 87 0.8× 160 1.5× 64 0.7× 51 0.6× 69 869
Lei Xia China 17 425 0.7× 107 0.9× 125 1.2× 59 0.6× 54 0.6× 65 988
Dandan Song China 19 395 0.6× 107 0.9× 160 1.5× 61 0.6× 28 0.3× 59 841
Zhiwei Ye United States 16 659 1.0× 65 0.6× 85 0.8× 82 0.9× 31 0.3× 42 1.1k

Countries citing papers authored by Ran Xu

Since Specialization
Citations

This map shows the geographic impact of Ran Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xu more than expected).

Fields of papers citing papers by Ran Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xu. The network helps show where Ran Xu may publish in the future.

Co-authorship network of co-authors of Ran Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Xu. A scholar is included among the top collaborators of Ran Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Xu. Ran Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ran, et al.. (2026). Association of biological age markers with stroke prevalence: Insights from a cross-sectional study. Journal of the Neurological Sciences. 483. 125843–125843.
2.
Xu, Ran, et al.. (2025). Workplace bullying and its relationship with spiritual climate: a latent profile analysis. Frontiers in Psychology. 16. 1516345–1516345.
3.
He, Quanwei, Xiujuan Chang, Ran Xu, et al.. (2025). Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021. Frontiers in Public Health. 12. 1494388–1494388. 1 indexed citations
4.
Lu, Jihui, Zhenyuan Yang, Ran Xu, et al.. (2025). A self-assembly enzyme-like hydrogel with ROS scavenging and immunomodulatory capability for microenvironment-responsive wound healing acceleration. International Journal of Pharmaceutics. 675. 125529–125529. 2 indexed citations
5.
Jin, Lei, Heather A. Sullivan, Thomas K. Lavin, et al.. (2024). Long-term labeling and imaging of synaptically connected neuronal networks in vivo using double-deletion-mutant rabies viruses. Nature Neuroscience. 27(2). 373–383. 2 indexed citations
6.
Zhang, Yu, Wei Luo, Caihong Lv, et al.. (2024). HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis. Current Cancer Drug Targets. 25(2). 144–158. 8 indexed citations
8.
Gao, Lifang, et al.. (2024). Inability of recognizing offspring underlies parental errors in the selection of offspring. Avian Research. 16(1). 100218–100218. 1 indexed citations
9.
Zhou, Xiang, Rongjian Xu, Tong Lu, et al.. (2023). Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma. Aging. 15(16). 8090–8112. 1 indexed citations
10.
Lü, Tong, Ran Xu, Xiang Zhou, et al.. (2023). Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma. Journal of Thoracic Disease. 15(7). 3885–3907. 9 indexed citations
11.
Shi, Jiaxin, Bo Peng, Xiang Zhou, et al.. (2023). An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration. Journal of Cancer Research and Clinical Oncology. 149(13). 12089–12102. 2 indexed citations
12.
Xu, Ran, Luca Peruzza, Massimiliano Babbucci, et al.. (2022). Multi-tissue RNA-Seq Analysis and Long-read-based Genome Assembly Reveal Complex Sex-specific Gene Regulation and Molecular Evolution in the Manila Clam. Genome Biology and Evolution. 14(12). 11 indexed citations
13.
Zhou, Shuai, Ran Xu, Dongping Wei, et al.. (2022). TRIM27 cooperates with STK38L to inhibit ULK1‐mediated autophagy and promote tumorigenesis. The EMBO Journal. 41(14). e109777–e109777. 39 indexed citations
14.
Wang, Chenghao, Tong Lu, Ran Xu, et al.. (2022). A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments. Journal of Thoracic Disease. 14(6). 2131–2146. 3 indexed citations
15.
Wang, Jun, Huawei Li, Ran Xu, et al.. (2022). The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery. BMC Pulmonary Medicine. 22(1). 104–104. 36 indexed citations
16.
Zhang, Zhuojun, Ran Xu, Shuo Wei, et al.. (2022). A spray-filming, tissue-adhesive, and bioactive polysaccharide self-healing hydrogel for skin regeneration. Materials & Design. 217. 110669–110669. 31 indexed citations
18.
Xu, Ran, Jiaying Zhao, Qi Li, et al.. (2021). Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma. Annals of Translational Medicine. 9(22). 1692–1692. 2 indexed citations
19.
Wu, Shuiqing, Xiaokun Zhao, Yinhuai Wang, et al.. (2018). Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies. Cellular Physiology and Biochemistry. 46(4). 1352–1364. 24 indexed citations
20.
Chen, Jing, et al.. (2014). The change of cystatine C in Parkinson’s disease patients with obstructive sleep apnea syndrome. Chin J Neurol. 47(6). 365–369. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026